Press release
Respiratory drug delivery Market 2018: AptarGroup S. A.,Novartis, Roche,TTP plc,Hovione,Teva Pharmaceutical, OMRON Group, Catalent Pharma Solutions., Sunovion Pharmaceuticals., Cipla, GlaxoSmithKline Pharma GmbH,3M, AstraZeneca, Merck
Global Pulmonary/Respiratory Drug Delivery Market
This report by Databridgemarketresearch brings all the figures needed to achieve in a stand point in the Pulmonary / respiratory drug delivery market by showing all the recent developments, product launches, joint ventures, merges and accusations done by the key players and brands that are making a mark in the market. While also informing what the market drivers and restrains are with the help of SWOT analysis.
global pulmonary or respiratory drug delivery market is expected to reach USD 63.79 billion by 2025, from USD 38.63 billion in 2017 growing at a CAGR of 6.7% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-pulmonary-respiratory-drug-delivery-market
Global Pulmonary/Respiratory Drug Delivery Market, By Canister Type (Plain Canisters, Coated Canister), Application (Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis), End User (Hospitals & Clinics, Home Care Settings), Formulation, Geography (North America, South America, Europe, Asia-Pacific, Middle East And Africa)– Industry Trends and Forecast to 2025
Key Developments in the Market:
• In March 2016, FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome.
• In April 2013, Bayer Healthcare launched a hormonal intrauterine device (IUD) called Skyla. The product is launched in Europe with the brand name Jaydess, and is used for the prevention of pregnancy for up to three years.
Competitors/Players: Global Pulmonary/Respiratory Drug Delivery Market
• GlaxoSmithKline Pharma GmbH
• 3M,
• AstraZeneca,
• Boehringer Ingelheim
• Philips,
• PARI,
• GF Health Products Inc.,
• Merck
• Progressive Trade Media Limited
• BeyonDevices,
• Lda,
• Aphios Corporation,
• AptarGroup S. A.
• Novartis,
• Roche,
• TTP plc,
• Hovione,
• Teva Pharmaceutical,
• OMRON Group,
• Catalent Pharma Solutions.
• Sunovion Pharmaceuticals.,
• Cipla
• among others.
Competitive Analysis: Global Pulmonary/Respiratory Drug Delivery Market
The global pulmonary/respiratory drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pulmonary/respiratory drug delivery market for global, Europe, North America, Asia Pacific and South America.
Table of Contents:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports
Request for Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-pulmonary-respiratory-drug-delivery-market
Major Market Drivers and Restraints:
• Growing preference for pulmonary drug delivery as an alternate route of drug delivery
• Development of smart/digital inhalers
• Increasing respiratory diseases
• Regulatory issues
• Pricing pressure
Primary Respondents
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others
Reasons to Purchase this Report
• Current and future of global pulmonary/respiratory drug delivery market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Request Analyst Call at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-pulmonary-respiratory-drug-delivery-market
Market Segmentation: Global Pulmonary/Respiratory Drug Delivery Market
The Global Pulmonary/Respiratory Drug Delivery Market is segmented based on
• Canister Type,
• Application,
• End User,
• Formulation
• Geography
By formulation the global pulmonary/respiratory drug delivery market is segmented into type and device type. Type is further sub segmented into
• suspension aerosols,
• solution aerosols and
• dry powder formulations.
• Device type metered dose inhalers (MDIS),
• dry powder inhalers (DPIS)
• nebulizers.
Nebulizers are further sub segmented into
• jet nebulizers,
• ultrasonic nebulizers
• soft mist nebulizers.
By canister type the global pulmonary/respiratory drug delivery market is segmented into
• plain canisters
• coated canister.
On the basis of application the global pulmonary/respiratory drug delivery market is segmented into
• chronic obstructive pulmonary disease,
• asthma,
• cystic fibrosis
• others.
On the basis of end user the global pulmonary/respiratory drug delivery market is segmented into
• hospitals & clinics
• home care settings.
Based on geography, the market report covers data points for 28 countries across multiple geographies namely
• North America & South America,
• Europe,
• Asia-Pacific and,
• Middle East & Africa.
Customization of the Report
• All segmentation provided above in this report is represented at country level. All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.
Customization With Discount Available On This Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pulmonary-respiratory-drug-delivery-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavorsto provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory drug delivery Market 2018: AptarGroup S. A.,Novartis, Roche,TTP plc,Hovione,Teva Pharmaceutical, OMRON Group, Catalent Pharma Solutions., Sunovion Pharmaceuticals., Cipla, GlaxoSmithKline Pharma GmbH,3M, AstraZeneca, Merck here
News-ID: 1255962 • Views: …
More Releases from Data Bridge Market Research
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size
The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness.
Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the…
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size
Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation…
Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size
The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent…
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into…
More Releases for Pulmonary
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Embolism - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Embolism - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism - Pipeline Review, H2 2017, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape.
Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood…
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot
The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
